CEMIP expression is reported to be elevated in demyelinating MS lesions (20), and an inhibitor that blocks the activities of some hyaluronidases, including CEMIP, increased functional recovery in a rodent model of MS (21). This evidence concerns the gene CEMIP and myeloid sarcoma.